Page last updated: 2024-10-29

staurosporine aglycone and Leukemia, Myeloid, Acute

staurosporine aglycone has been researched along with Leukemia, Myeloid, Acute in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, R1
Nalluri, S1
Fiskus, W1
Balusu, R1
Joshi, A1
Mudunuru, U1
Buckley, KM1
Robbins, K1
Ustun, C1
Reuther, GW1
Bhalla, KN1

Other Studies

1 other study available for staurosporine aglycone and Leukemia, Myeloid, Acute

ArticleYear
Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:8

    Topics: Animals; Benzoquinones; Bone Marrow Cells; Carbazoles; Cell Differentiation; Cell Line, Tumor; Cocul

2010